[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:psoriatic-arthritis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":236,"states":237},"Psoriatic Arthritis",37,28,[8,16,23,30,36,42,48,54,61,67,73,79,85,91,97,103,109,115,121,127,132,138,144,150,156,162,168,174,180,187,192,199,205,211,218,224,230],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07321873","A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis",[12],"Phase 2","RECRUITING","2026-08-26T02:17:13.277148Z","2026-07-05T05:32:16.674848Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06807424","A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis",[20],"Phase 3","2026-08-26T02:16:45.157238Z","2026-06-16T05:54:07.923432Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06454188","A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis",[27],"Phase 4","2026-08-26T02:17:35.666428Z","2026-05-05T02:43:29.328956Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT06865105","Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis",[12],"2026-08-26T02:15:51.395565Z","2026-05-05T02:43:29.215942Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06641089","Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response",[20],"2026-08-26T02:16:33.772093Z","2026-05-05T02:43:29.026027Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06671483","A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines",[20],"2026-08-26T02:16:39.977107Z","2026-05-05T02:43:28.841036Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06671496","A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines",[20],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:28.566771Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":59,"content_modified":60},"NCT07290036","A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults",[58],"Phase 1","2026-08-26T02:15:09.079045Z","2026-05-05T02:43:28.020402Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT07486960","Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)",[12],"2026-08-26T02:18:23.582895Z","2026-05-05T02:43:27.839212Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT05669833","Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients",[20],"2026-08-26T02:17:06.985283Z","2026-05-05T02:43:27.825834Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT07111494","Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial",[27],"2026-08-26T02:16:27.227548Z","2026-05-05T02:43:27.609053Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT07286058","Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis",[20],"2026-08-26T02:17:39.048487Z","2026-05-05T02:43:27.061680Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06864026","A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)",[27],"2026-08-26T02:16:03.788292Z","2026-05-05T02:43:28.114249Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT07138898","Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty",[12],"2026-08-26T02:16:54.876240Z","2026-05-05T02:43:27.643948Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT03816345","Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO",[58],"2026-08-26T02:16:10.529598Z","2026-05-05T02:43:26.680299Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT05652608","Stronger Together Psoriatic Arthritis Wellness Study",[],"2026-08-26T02:16:06.684983Z","2026-05-13T02:55:06.367033Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT04846959","Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications",[],"2026-08-26T02:16:44.178623Z","2026-05-13T02:55:06.271941Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT02103361","Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project",[],"2026-08-26T02:15:23.202838Z","2026-05-13T02:55:06.081507Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT06339957","Rheumatology Diet Study",[],"2026-08-26T02:19:09.651016Z","2026-05-13T02:55:06.482572Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":21,"content_modified":131},"NCT05883371","IMPACT - AndHealth Autoimmune Research Registry",[],"2026-05-13T02:55:06.391385Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT04751396","Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors",[],"2026-08-26T02:17:12.307088Z","2026-05-13T02:55:06.267732Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT04402086","Rheumatology Patient Registry and Biorepository",[],"2026-08-26T02:18:39.640967Z","2026-05-13T02:55:06.248878Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT03276923","Maternal Autoimmune Disease Research Alliance (MADRA) Registry",[],"2026-08-26T02:18:00.873391Z","2026-05-13T02:55:06.121380Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT02418442","Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry",[],"2026-08-26T02:19:19.162260Z","2026-05-13T02:55:06.095430Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":160,"content_modified":161},"NCT06586281","Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy",[],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:28.215735Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT06888193","A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)",[58],"2026-08-26T02:17:07.954622Z","2026-05-05T02:43:29.527790Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT04504136","Regulation of Mucosal Healing in Inflammatory Bowel Disease",[],"2026-08-26T02:18:30.351130Z","2026-05-05T02:43:27.663576Z",{"nct_id":175,"title":176,"phases":177,"status":13,"updated_at":178,"content_modified":179},"NCT07180537","Creating Health Course Study for People With Rheumatological Conditions",[],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:26.957955Z",{"nct_id":181,"title":182,"phases":183,"status":184,"updated_at":185,"content_modified":186},"NCT07280702","Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease",[27],"NOT_YET_RECRUITING","2026-08-26T02:17:51.502023Z","2026-05-05T02:35:31.931209Z",{"nct_id":188,"title":189,"phases":190,"status":184,"updated_at":160,"content_modified":191},"NCT07654751","A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically",[27],"2026-06-17T19:21:16.688064Z",{"nct_id":193,"title":194,"phases":195,"status":196,"updated_at":197,"content_modified":198},"NCT07223138","A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis",[20],"ENROLLING_BY_INVITATION","2026-08-26T02:18:52.966503Z","2026-06-16T05:54:07.874429Z",{"nct_id":200,"title":201,"phases":202,"status":196,"updated_at":203,"content_modified":204},"NCT04277416","Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty",[],"2026-08-26T02:17:45.190188Z","2026-07-05T18:42:10.724709Z",{"nct_id":206,"title":207,"phases":208,"status":196,"updated_at":209,"content_modified":210},"NCT06989281","Evaluation of a Primary Care Based Lifestyle Medicine Clinic at UAB",[],"2026-08-26T02:15:46.655893Z","2026-06-16T05:54:07.845084Z",{"nct_id":212,"title":213,"phases":214,"status":215,"updated_at":216,"content_modified":217},"NCT06506916","A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:32.170340Z","2026-05-05T02:43:27.949868Z",{"nct_id":219,"title":220,"phases":221,"status":215,"updated_at":222,"content_modified":223},"NCT07148414","A Study of SPY072 in Rheumatic Disease",[12],"2026-08-03T02:35:07.436307Z","2026-05-05T02:35:31.873882Z",{"nct_id":225,"title":226,"phases":227,"status":215,"updated_at":228,"content_modified":229},"NCT04110522","Psoriatic Arthritis D2P Screening",[],"2026-08-03T03:50:55.473026Z","2026-05-05T02:43:27.193920Z",{"nct_id":231,"title":232,"phases":233,"status":215,"updated_at":234,"content_modified":235},"NCT05621369","Psorcast Mobile Study",[],"2026-08-03T03:36:04.680662Z","2026-05-13T02:55:06.364720Z",[],[238,242,245,248,252,256,260,264,268,271,274,278,282,285,288,292,295,299,302,305,308,311,314,317],{"state":239,"count":240,"slug":241},"California",17,"california",{"state":243,"count":240,"slug":244},"Florida","florida",{"state":246,"count":240,"slug":247},"Texas","texas",{"state":249,"count":250,"slug":251},"Pennsylvania",16,"pennsylvania",{"state":253,"count":254,"slug":255},"Ohio",14,"ohio",{"state":257,"count":258,"slug":259},"North Carolina",13,"north-carolina",{"state":261,"count":262,"slug":263},"Illinois",11,"illinois",{"state":265,"count":266,"slug":267},"Arizona",10,"arizona",{"state":269,"count":266,"slug":270},"Maryland","maryland",{"state":272,"count":266,"slug":273},"New York","new-york",{"state":275,"count":276,"slug":277},"Tennessee",9,"tennessee",{"state":279,"count":280,"slug":281},"Georgia",8,"georgia",{"state":283,"count":280,"slug":284},"Michigan","michigan",{"state":286,"count":280,"slug":287},"Washington","washington",{"state":289,"count":290,"slug":291},"Massachusetts",5,"massachusetts",{"state":293,"count":290,"slug":294},"Missouri","missouri",{"state":296,"count":297,"slug":298},"Alabama",4,"alabama",{"state":300,"count":297,"slug":301},"Arkansas","arkansas",{"state":303,"count":297,"slug":304},"Colorado","colorado",{"state":306,"count":297,"slug":307},"Kentucky","kentucky",{"state":309,"count":297,"slug":310},"New Mexico","new-mexico",{"state":312,"count":297,"slug":313},"Oregon","oregon",{"state":315,"count":297,"slug":316},"Utah","utah",{"state":318,"count":297,"slug":319},"Wisconsin","wisconsin"]